P08.60 Primary Procarbazine, Lomustine, and Vincristine (PCV) chemotherapy (CT) in grade II/III 1p19q co-deleted gliomas: The Royal Marsden experience

Por Coleman, N. J., Alken, S., Welsh, L., Johns, P., Saran, F.
Publicado no Neuro Oncol (2016)

SAT-486 A Unique Case of Pituitary Macroadenoma Unmasked by Glucocorticoid Treatment

Por Boddhula, Sowmya, Boddhula, Satish, Hughes, Joseph
Publicado no J Endocr Soc (2019)

P06.08 SYSTEMIC TREATMENT OF MENINGIOMAS: IS THERE A ROLE FOR LONG-ACTING SOMATOSTATIN?

Por Magistrello, M., Trevisan, E., Bertero, L., Pellerino, A., Rudà, R., Soffietti, R.
Publicado em 2014

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma

Por Doehn, Christian, Grünwald, Viktor, Steiner, Thomas, Follmann, Markus, Rexer, Heidrun, Krege, Susanne
Publicado no Dtsch Arztebl Int (2016)

Establishment of a 12-gene expression signature to predict colon cancer prognosis

Por Sun, Dalong, Chen, Jing, Liu, Longzi, Zhao, Guangxi, Dong, Pingping, Wu, Bingrui, Wang, Jun, Dong, Ling
Publicado no PeerJ (2018)

BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study

Por Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek, Hollebecque, Antoine, Rodon, Jordi, Lockhart, A. Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves, Chau, Ian, Puzanov, Igor, Raje, Noopur S., Wolf, Jurgen, DeAngelis, Lisa M., Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose, Hyman, David M.
Publicado no J Clin Oncol (2018)

Session 1

Publicado em 2014

Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia

Por Pui, C-H, Pei, D, Sandlund, JT, Ribeiro, RC, Rubnitz, JE, Raimondi, SC, Onciu, M, Campana, D, Kun, LE, Jeha, S, Cheng, C, Howard, SC, Metzger, ML, Bhojwani, D, Downing, JR, Evans, WE, Relling, MV
Publicado em 2009

Quantified Visual Scoring of Metastatic Melanoma Patient Treatment Response Using Computed Tomography: Improving on the Current Standard

Por Gottlieb, Ronald H., Krupinski, Elizabeth, Chalasani, Pavani, Cranmer, Lee
Publicado em 2011

Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis

Por Song, Jie, Xue, Yue-Qin, Zhao, Ming-Ming, Xu, Peng
Publicado no Onco Targets Ther (2018)

Toxicological and efficacy assessment of post-transition metal (Indium) phthalocyanine for photodynamic therapy in neuroblastoma

Por Neagu, Monica, Constantin, Carolina, Tampa, Mircea, Matei, Clara, Lupu, Andreea, Manole, Emilia, Ion, Rodica-Mariana, Fenga, Concettina, Tsatsakis, Aristidis M.
Publicado no Oncotarget (2016)

Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia

Por Schwarz, Philip, Meier, Valeria, Soukup, Alena, Drees, Randi, Besserer, Jürgen, Beckmann, Katrin, Roos, Malgorzata, Rohrer Bley, Carla
Publicado no J Vet Intern Med (2018)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Por Paweł Rogala, Anna M. Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Ziętek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Natasza Kempa-Kamińska, Joanna Seredyńska, Wiesław Bal, Katarzyna Kozak, Anna Surus-Hyla, Tomasz Kubiatowski, Grażyna Kamińska-Winciorek, Rafał Suwiński, Jacek Mackiewicz, Piotr Rutkowski
Publicado em 2022-04-01

Ensartinib (X-396) in ALK-positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Por Horn, Leora, Infante, Jeffrey R., Reckamp, Karen L., Blumenschein, George R., Leal, Ticiana A., Waqar, Saiama N., Gitlitz, Barbara J., Sanborn, Rachel E., Whisenant, Jennifer G., Du, Liping, Neal, Joel W., Gockerman, Jon P., Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J., Holzhausen, Allison, Lovly, Christine M., Wakelee, Heather A.
Publicado no Clin Cancer Res (2018)

TrkB Inhibition by GNF-4256 Slows Growth and Enhances Chemotherapeutic Efficacy in Neuroblastoma Xenografts

Por Croucher, Jamie L., Iyer, Radhika, Li, Nanxin, Molteni, Valentina, Loren, Jon, Gordon, W. Perry, Tuntland, Tove, Liu, Bo, Brodeur, Garrett M.
Publicado no Cancer Chemother Pharmacol (2014)

NTOX-11. DISEASE OUTCOMES, TOXICITY PROFILES, AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING INTRA-ARTERIAL CARBOPLATIN SALVAGE THERAPY

Por Babcock, Anna, Hultman, Meghan, Bruns, Patricia, Gilliland, Katheryn, Schrecengost, Amy, Trusheim, John, Banerji, Nilanjana
Publicado no Neuro Oncol (2017)

Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patients

Por Truntzer, Pierre, Antoni, Delphine N, Santelmo, Nicola, Schumacher, Catherine, Falcoz, Pierre-Emmanuel, Quoix, Elisabeth, Steib, Jean-Pierre, Massard, Gilbert, Noël, Georges
Publicado no Radiat Oncol (2014)

Poster Session B

Publicado no Mol Cell Proteomics (2019)

Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors

Por Song, Peng, Zhang, Jingcheng, Shang, Congcong, Zhang, Li
Publicado no Sci Rep (2019)

P10.03 Management of low-grade glioma: a systematic review and meta-analysis

Por Brown, T. J., Bota, D., Maher, E., Aregawi, D., Liau, L. M., Buckner, J., Weller, M., van den Bent, M. J., Berger, M. S., Glantz, M.
Publicado no Neuro Oncol (2017)